HE4 biomarker predicts risk in AHF with CKD
Dove Medical Press — April 2, 2024, 08:00 AM UTC
Summary: Acute heart failure (AHF) combined with chronic kidney disease (CKD) poses a significant risk, with readmission rates up to 44% and a mortality rate of 30% within a year. Human epididymis protein 4 (HE4) emerges as a promising biomarker for prognosis, showing a positive correlation with NT-proBNP and a negative correlation with eGFR. Patients with HE4 levels >276.15 pmol/L have a 2.52-fold higher risk of adverse events.
Article metrics
Significance6.0
Scale & Impact0.0
Positivity6.0
Credibility8.0
What is this?
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
We analyze up to 10,000 news articles daily and find the most significant world news.
Read more about how we calculate significance, or see today's top rated news on the main page:
See today's news rankings